Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/225733
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Developing Diagnostic and Therapeutic Approaches to Bacterial Infections for a New Era: Implications of Globalization |
Autor: | Fernández Llamas, Lucía CSIC ORCID; Cima-Cabal, María Dolores; Duarte, Ana Catarina; Rodríguez González, Ana CSIC ORCID; García Suárez, María Pilar CSIC ORCID ; García-Suárez, María del Mar | Palabras clave: | Infectious diseases Antibiotic resistance Diagnostic systems New therapies Globalization |
Fecha de publicación: | 16-dic-2020 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Antibiotics 9(12): 916 (2020) | Resumen: | In just a few months, the current coronavirus pandemic has exposed the need for a more global approach to human health. Indeed, the quick spread of infectious diseases and their unpredictable consequences, in terms of human lives and economic losses, will require a change in our strategy, both at the clinical and the research level. Ultimately, we should be ready to fight against infectious diseases affecting a huge number of people in different parts of the world. This new scenario will require rapid, inexpensive diagnostic systems, applicable anywhere in the world and, preferably, without the need for specialized personnel. Also, treatments for these diseases must be versatile, easily scalable, cheap, and easy to apply. All this will only be possible with joint support of the governments, which will have to make the requirements for the approval of new therapies more flexible. Meanwhile, the pharmaceutical sector must commit to prioritizing products of global interest over the most profitable ones. Extreme circumstances demand a vehement response, and any profit losses may well pay dividends going forward. Here, we summarize the developing technologies destined to face the current and future health challenges derived from infectious diseases and discuss which ones have more possibilities of being implemented. | Descripción: | © 2020 by the authors. | Versión del editor: | https://doi.org/10.3390/antibiotics9120916 | URI: | http://hdl.handle.net/10261/225733 | DOI: | 10.3390/antibiotics9120916 | E-ISSN: | 2079-6382 |
Aparece en las colecciones: | (IPLA) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Developing_Fernandez_PV_.Art2020.pdf | 1,2 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
7
checked on 20-mar-2024
SCOPUSTM
Citations
10
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
5
checked on 25-feb-2024
Page view(s)
139
checked on 23-abr-2024
Download(s)
340
checked on 23-abr-2024